Apoptotic activity of isomalabaricane triterpenes on human promyelocytic leukemia HL60 cells

Cancer Letters

Volumn 230, Issue 1, 2005, Pages 102-110

  Liu, W K ^a   Ho, J C K ^a   Che, C T ^b  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Caspases 3; Mitochondrial membrane potential; Reactive oxidative species

Indexed keywords

ANTILEUKEMIC AGENT; CASPASE 3; CYCLINE; FLUORESCEIN ISOTHIOCYANATE; GEODITIN A; GEODITIN B; LIPOCORTIN 5; REACTIVE OXYGEN METABOLITE; STELLETIN A; STELLETIN B; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; ENZYME ACTIVATION; FLOW CYTOMETRY; FLUORESCENCE; GEODIA JAPONICA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; LEUKEMIA CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; SIGNAL TRANSDUCTION; SPONGE (PORIFERA);

ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GEODIA; HL-60 CELLS; HUMANS; MEMBRANE POTENTIALS; MITOCHONDRIA; REACTIVE OXYGEN SPECIES; RESORCINOLS; TRITERPENES;

GEODIA; JAPONICA;

EID: 27144490732     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.12.034     Document Type: Article

References (24)

1. W.H. Zhang, and C.T. Che Isomalabaricane-type nortriterpenoids and other constituents of the marine sponge Geodia japonica J. Nat. Prod. 64 2001 1489 1492
2. B. Nuijen, M. Bouma, C. Manada, J.M. Jimeno, J.H. Schellens, A. Bult, and J.H. Beijnen Pharmaceutical development of anticancer agents derived from marine sources Anticancer Drugs 11 2000 793 811
3. M.H. Munro, J.W. Blunt, E.J. Dumdei, S.J. Hickford, R.E. Lill, and S. Li The discovery and development of marine compounds with pharmaceutical potential J. Biotechnol. 70 1999 15 25
4. W. Fenical New pharmaceuticals from marine organisms Trends Biotechnol. 15 1997 339 341
5. J.C. De Freitas, F. Rodrigue, P. Lavaud, J.M. Mencia-Huerta, and P. Braquet Inhibition of platelet aggregation by manoalide: preliminary results Braz. J. Med. Biol. Res. 21 1988 337 340
6. A. Takai Okadaic acid. Protein phosphatase inhibition and muscle contractile effects J. Muscle Res. Cell Motil. 9 1988 563 565
7. T. McCabe, J. Clardy, L. Minale, C. Pizza, F. Zollo, and R. Riccio A triterpenoid pigment with the isomalabaricane skeleton from the marine sponge Tetrahedron Lett. 23 1982 3307 3310
8. T.C. McKee, H.R. Bokesch, J.L. McCormick, M.A. Rashid, D. Spielvogel, and K.R. Gustafson Isolation and characterization of new anti-HIV and cytotoxic leads from plants, marine, and microbial organisms J. Nat. Prod. 60 1997 431 438
9. D. Tasdemir, G.C. Mangalindan, G.P. Concepcion, S.M. Verbitski, S. Rabindran, and M. Miranda Bioactive isomalabaricane triterpenes from the marine sponge Rhabdastrella globostellata J. Nat. Prod. 65 2002 210 214
10. J.Y. Su, Y.H. Meng, L.M. Zeng, X. Fu, and F.J. Schmitz Stellettin A, a new triterpenoid pigment from the marine sponge Stelletta tenuis J. Nat. Prod. 57 1994 1450 1451
11. W.K. Liu, J.C.K. Ho, F.W.K. Cheung, B.P.L. Liu, W.C. Ye, and C.T. Che Apoptotic activity of betulinic acid derivatives on murine melanoma B16 cell line Eur. J. Pharmacol. 498 2004 71 78
12. K. Gilmore, and M. Wilson The use of chloromethyl-X-rosamine (Mitotracker red) to measure loss of mitochondrial membrane potential in apoptotic cells is incompatible with cell fixation Cytometry 36 1999 355 358
13. D.V. Krysko, F. Roels, L. Leybaert, and K. D'Herde Mitochondrial transmembrane potential changes support the concept of mitochondrial heterogeneity during apoptosis J. Histochem. Cytochem. 49 2001 1277 1284
14. R. Kim, K. Tanabe, Y. Uchida, M. Emi, H. Inoue, and T. Toge Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy Cancer Chemother. Pharmacol. 50 2002 343 352
15. P. Costantini, E. Jacotot, D. Decaudin, and G. Kroemer Mitochondrion as a novel target of anticancer chemotherapy J. Natl Cancer Inst. 92 2000 1042 1053
16. P. Sancho, A. Troyano, C. Fernandez, E. De Blas, and P. Aller Differential effects of catalase on apoptosis induction in human promonocytic cells. Relationships with heat-shock protein expression Mol. Pharmacol. 63 2003 581 589
17. C. Yu, G. Krystal, P. Dent, and S. Grant Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cells Clin. Cancer Res. 8 2002 2976 2984
18. E. De Clercq New developments in anti-HIV chemotherapy Curr. Med. Chem. 8 2001 1543 1572
19. M.J. Towle, K.A. Salvato, J. Budrow, B.F. Wels, G. Kuznetsov, and K.K. Aalfs In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B Cancer Res. 61 2001 1013 1021
20. K.A. Hood, L.M. West, B. Rouwe, P.T. Northcote, M.V. Berridge, S.J. Wakefield, and J.H. Miller Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule-stabilizing activity Cancer Res. 62 2002 3356 3360
21. D.J. Newman, G.M. Cragg, and K.M. Snader The influence of natural products upon drug discovery Nat. Prod. Rep. 17 2000 215 234
22. G. Schwartsmann Marine organisms and other novel natural sources of new cancer drugs Ann. Oncol. 11 2000 235 243
23. W.K. Liu, J.C.K. Ho, G.W. Qin, and C.T. Che Jolkinolide b induces neuroendocrine differentiation of human prostate LNCaP cancer cell line Biochem. Pharmacol. 63 2002 951 957
24. B.D. Follstad, D.I. Wang, and G. Stephanopoulos Mitochondrial membrane potential differentiates cells resistant to apoptosis in hybridoma cultures Eur. J. Biochem. 267 2000 6534 6540